Centocor ( CNTO ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO )

CNTO 0.00001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: SG who wrote (571)	3/9/1998 9:33:00 PM
From: Wilfredo Pagani	Read Replies (3) of 965

Avakine seems to require more time to be used at office levels . Its appear to require intravenous infussion for two hours , not clear about dose and how many times it had to be given in a year. It seems to be reserved for the research hospitals for getting more information. No evidence to suggest that it will be used in all Crohns patients , probably only in those that failed to usual therapy. Little concern with medicolegal trouble. WPagani

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next